COEP Short Interest

Coeptis Therapeutics, Inc. (COEP) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $57.6M, listed on NASDAQ, employing roughly 5 people, carrying a beta of -0.43 to the broader market. Coeptis Therapeutics, Inc. Led by David Mehalick, public since 2020-12-17.

Short interest is the total number of shares currently sold short and not yet covered, reported bi-monthly by FINRA. Days to cover (short interest divided by average daily volume) indicates how long it would take short sellers to close positions, with higher values signaling greater squeeze potential.

Settlement Date

2026-04-15

Short Interest

429.8K

Previous Short Interest

376.3K

Change

14.22%

Days to Cover

9.84

Avg Daily Volume

43.7K

Avg Days to Cover (24 reports)

4.10

Showing 24 bi-monthly FINRA short interest reports for Coeptis Therapeutics, Inc..

Learn how short interest is reported and how to read the data →